2m 2m 2m 2m 2m 2m 2m
TANDEM DIABETES (TNDM)
NASDAQ
$14.58+$0.17 (+1.18%)
Price as of Jun 23, 2026 5:39 PM EDT- $982.7MMarket Cap
- -29.08%1-Year Change
- Medical DevicesIndustry
TANDEM DIABETES (TNDM)
$14.58+$0.17 (+1.18%)
TNDM | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $14.41 | ||
Change | -$0.96 (-6.27%) | ||
Open | $14.17 | ||
High | $14.48 | ||
Low | $13.95 | ||
Previous Close | $14.34 | ||
Volume | 3,498,148 | ||
30-Day Average Volume | 2,713,291 | ||
1-Week Change | -14.44% | ||
1-Month Change | -4.18% | ||
1-Year Change | -29.08% | ||
3-Year Change | -45.64% | ||
5-Year Change | -84.94% | ||
Fundamentals | |||
Shares Outstanding | 68.5M | ||
Total Assets | $1.2B | ||
Market Cap | $982.7M | ||
Enterprise Value | $1.4B | ||
Period: QTR TTM FY | |||
Revenue | $247.2M | ||
Net Income | -$20.4M | ||
Free Cash Flow | $4.8M | ||
EBIT | -$18.1M | ||
EBITDA | -$13.6M | ||
Net Working Capital | $639.1M | ||
EPS | -$0.30 | ||
Enterprise Value/EBITDA | -103 | ||
Enterprise Value/Revenue | 6 | ||
P/B | 7 | ||
P/E | -48 | ||
PEG | 0 | ||
Price/Free Cash Flow | 205 | ||
Price/Operating Cash Flow | 89 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 10/10/2017 | ||
Earnings & Revenue